Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11912703 6-azaindole compounds

Patent 11912703 was granted and assigned to Bristol-Myers Squibb Company on February, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Bristol-Myers Squibb Company

0

Current Assignee

Bristol-Myers Squibb Company

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Srinivasan Kunchithapatham Duraisamy0

Alaric J. Dyckman0

Durga Buchi Raju Barre0

Sreekantha Ratna Kumar0

Dharmpal S. Dodd0

Date of Patent

February 27, 2024

0

Patent Application Number

178540890

Date Filed

June 30, 2022

0

Patent Citations

US Patent 9126999 Tetrahydropyrazolopyrimidine compounds

0

US Patent 9241991 Agents, compositions, and methods for treating pruritus and related skin conditions

0

US Patent 9249140 Bicyclic heteroaromatic compounds

0

US Patent 9353115 Immune system modulators

0

US Patent 9376398 Carboxylic acid compounds

0

US Patent 9643967 Pyrrolo[3,2-c]pyridine derivatives as TLR inhibitors

0

US Patent 9428495 Selectively substituted quinoline compounds

0

US Patent 6867200 (Hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors

0

...

Patent Primary Examiner

Niloofar Rahmani

0

CPC Code

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11912703 6-azaindole compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool